An update on the Tissue Organization Field Theory
The TOFT predicts that neoplastic phenotypes are potentially reversible through cell-cell and/
or tissue-tissue interactions. This has been verified experimentally [38-40]. A now classical
example is the normalization of teratocarcinoma cells injected into blastocysts [41]. Moreover,
nuclei from a variety of cancer cells transplanted into enucleated oocytes could support normal
pre- and post-implantation development [42,43]. Also, modification of extracellular matrix
components resulted in normalization of the neoplastic phenotype [44-46].
The ability of normal tissues to reverse the neoplastic phenotype is subject to the age and
physiologic status of the host. For instance, mammary gland stroma from mature and
multiparous rats prevented neoplastic development and resulted, instead, in normal ductal
growth of grafted epithelial cancer cells [47]. This tumor development pattern suggests a
parallel to the phenomenon of age- and parity-dependent susceptibility and resistance to
chemical carcinogens in mammary gland neoplasia. As susceptibility to carcinogenesis
decreased with age, the ability of the stroma to normalize neoplastic epithelial cells increased.
This tissue-mediated, age-dependent normalization showed an inverted age-dependent pattern
when rat liver carcinoma cells were tested [48]. In addition, human metastatic melanoma cells
injected into zebra fish embryos acquired a non-neoplastic phenotype, while they formed
tumors when injected into zebrafish once organogenesis was completed [46]. Altogether, these
experiments suggest that the cancer phenotype is an adaptive, emergent phenomenon taking
place at the tissue level of organization.
Experiments designed under a theory-neutral strategy showed that the tissue recombination of
mammary gland stroma exposed to a carcinogen with unexposed, normal mammary epithelial
cells resulted in adenocarcinomas. However, the reverse combination did not [49]. This
observation suggests that the stroma, rather than the epithelium, was the target of the carcinogen
[50] and challenges the notion that carcinogens cause mammary gland adenocarcinomas by
mutating the DNA of the epithelial cells.
In sum, alterations in tissue architecture can and do induce neoplasms, and those neoplasms,
like the sporadic ones in humans, may end up showing aneuploidy [51] and even mutations
[10]. But, as Prehn remarked, “it may be more correct to say that cancers beget mutations than
it is to say that mutations beget cancers.” [52]. Nevertheless, some have recently proposed to
switch the focus of investigation to the search for hypothetical cancer-causing mutations now
in stromal cells [39,53]. It remains unclear how this alternative would overcome the
shortcomings of the SMT [54].
Dostları ilə paylaş: |